These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17084172)

  • 1. The case for secondary hormonal therapies in the chemotherapy age.
    Small EJ; Ryan CJ
    J Urol; 2006 Dec; 176(6 Pt 2):S66-71. PubMed ID: 17084172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary hormonal therapy for advanced prostate cancer.
    Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
    J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel secondary hormonal therapy in advanced prostate cancer: an update.
    Van Allen EM; Ryan CJ
    Curr Opin Urol; 2009 May; 19(3):315-21. PubMed ID: 19342958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hormonal manipulations in prostate cancer.
    Ryan CJ
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):925-34. PubMed ID: 16861123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hormone refractory prostate cancer: current standards and future prospects.
    Oh WK; Kantoff PW
    J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary hormonal therapy.
    Smith DC
    Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hormonal manipulations in prostate cancer.
    Ryan CJ; Small EJ
    Curr Oncol Rep; 2005 May; 7(3):228-33. PubMed ID: 15847715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in hormonal therapy for advanced prostate cancer.
    Daskivich TJ; Oh WK
    Curr Opin Urol; 2006 May; 16(3):173-8. PubMed ID: 16679855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for systemic therapy alone for prostate cancer.
    Sweeney C
    J Urol; 2006 Dec; 176(6 Pt 2):S42-6. PubMed ID: 17084165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms leading to the development of hormone-resistant prostate cancer.
    Kasper S; Cookson MS
    Urol Clin North Am; 2006 May; 33(2):201-10, vii. PubMed ID: 16631458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.
    Sartor O; Gomella LG; Gagnier P; Melich K; Dann R
    Can J Urol; 2009 Oct; 16(5):4806-12. PubMed ID: 19796455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for hormone-refractory prostate cancer: now it's a question of "when?".
    Ryan CJ; Eisenberger M
    J Clin Oncol; 2005 Nov; 23(32):8242-6. PubMed ID: 16278479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing prostate cancer: the role of hormone therapy.
    Ramirez ML; Keane TE; Evans CP
    Can J Urol; 2007 Dec; 14 Suppl 1():10-8. PubMed ID: 18163939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of resistance to antiandrogen therapy.
    Chen CD; Welsbie DS; Tran C; Baek SH; Chen R; Vessella R; Rosenfeld MG; Sawyers CL
    Nat Med; 2004 Jan; 10(1):33-9. PubMed ID: 14702632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel concepts in androgen receptor blockade.
    Hsieh AC; Ryan CJ
    Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for prostate cancer.
    Siddiqui K; Klotz LH
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):455-70. PubMed ID: 19650748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test.
    Ross JS
    Adv Anat Pathol; 2007 Sep; 14(5):353-7. PubMed ID: 17717436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hormonal manipulations in the management of advanced prostate cancer.
    Chaudhary UB; Rashid MH; Onitilo AA; Bissada NK
    Can J Urol; 2005 Jun; 12(3):2666-76. PubMed ID: 16011813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapies for non-metastatic prostate cancer: review of the literature.
    Jereczek-Fossa BA; Curigliano G; Orecchia R
    Onkologie; 2009 Jun; 32(6):359-63. PubMed ID: 19521126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.